{
    "2020-12-21": [
        [
            {
                "time": "2021-03-15",
                "original_text": "What Went Wrong With the Covid-19 Vaccine Trials",
                "features": {
                    "keywords": [
                        "Covid-19",
                        "vaccine",
                        "trials"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "INSIGHT- Inside J&J's Latam COVID vaccine trial, a rush to recruit is followed by disappointment",
                "features": {
                    "keywords": [
                        "J&J",
                        "Latam",
                        "COVID",
                        "vaccine",
                        "trial",
                        "disappointment"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "What it was like to volunteer for the J&J vaccine trial in Chile",
                "features": {
                    "keywords": [
                        "J&J",
                        "vaccine",
                        "trial",
                        "Chile"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-07-22",
                "original_text": "GlaxoSmithKline's ViiV Healthcare Bags EU Marketing Authorization For Long-Acting HIV Treatment",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "ViiV",
                        "Healthcare",
                        "EU",
                        "Marketing",
                        "Authorization",
                        "HIV",
                        "Treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}